Impero fascista : africani ed ebrei / Luigi Preti

• Record Nr.: UNISALENTO991003076969707536
• Autore: Preti, Luigi
• Pubbl/distr/stampa: Milano : Mursia, 1968
• Descrizione fisica: 375 p. : ill. ; 21 cm.
• Collana: Testimonianze fra cronaca e storia ; 28
• Soggetti: Fascismo - Politica coloniale; Fascismo - Politica razziale
• Lingua di pubblicazione: Italiano
• Formato: Materiale a stampa
• Livello bibliografico: Monografia

Prescription drug therapies [[electronic resource] ] : reducing costs and improving outcomes / / authors, Barbara L. Kass-Bartlemes, Lynn Bosco

• Record Nr.: UNINA9910696457603321
• Autore: Kass-Bartelmes Barbara L
• Pubbl/distr/stampa: Rockville, Md. : , : Agency for Healthcare Research and Quality, , [2002]
• Descrizione fisica: 11 pages : digital, PDF file
• Collana: Research in action ; ; issue #8; AHRQ pub. ; ; no. 02-0045
• Altri autori (Persone): BoscoLynn
• Soggetti: Prescription pricing - United States - Costs; Chemotherapy - Economic aspects - United States; Prescription Drugs - economics; Drug Therapy - economics; Drug Therapy - methods; United States
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Title from PDF caption (viewed Mar. 6, 2008).; "September 2002."
• Nota di bibliografia: Includes bibliographical references.
• Sommario/riassunto: The report describes Agency for Healthcare Research and Quality (AHRQ) funded research that helps to answer questions about prescription medicine. AHRQ research has identified conditions for which drug therapy is not necessary. It has discovered low-cost drug therapies that provide patients with the same quality of care as more expensive drugs. It has also revealed that sometimes the newest, most expensive drug therapy reduces costs overall because it keeps patients healthier and less likely to use other health care services. AHRQ has also finded research thatb investigated the cost effectiveness and safety of outpatient vs. inpatient services and the impact of preventive drug therapy.